Astellas Pharma (OTCMKTS:ALPMY) Shares Pass Below 50-Day Moving Average – Here’s What Happened

Astellas Pharma Inc. (OTCMKTS:ALPMY)’s stock price crossed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $9.76 and traded as low as $9.53. Astellas Pharma shares last traded at $9.53, with a volume of 211,118 shares trading hands.

Astellas Pharma Stock Down 0.1 %

The firm has a market capitalization of $17.25 billion, a P/E ratio of -43.32 and a beta of 0.34. The company has a fifty day simple moving average of $9.76 and a 200 day simple moving average of $10.92. The company has a quick ratio of 0.86, a current ratio of 1.10 and a debt-to-equity ratio of 0.41.

Astellas Pharma (OTCMKTS:ALPMY) last posted its quarterly earnings results on Tuesday, February 4th. The company reported $0.30 earnings per share (EPS) for the quarter. Astellas Pharma had a positive return on equity of 13.48% and a negative net margin of 3.10%. On average, equities analysts expect that Astellas Pharma Inc. will post 0.58 EPS for the current fiscal year.

Astellas Pharma Company Profile

Astellas Pharma Inc manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally. The company provides XTANDI, a treatment for prostate cancer; XOSPATA, a treatment for patients who have relapsed or refractory acute myeloid leukemia with a FLT3 mutation; and PADCEV, a treatment for patients with metastatic urothelial cancer.